Fluorinated Pseudopeptide Analogues of the Neuropeptide 26RFa: Synthesis, Biological, and Structural Studies

ChemBioChem

Volumn 14, Issue 13, 2013, Pages 1620-1633

  Pierry, Camille ^a   Couve Bonnaire, Samuel ^a   Guilhaudis, Laure ^a   Neveu, Cindy ^b   Marotte, Amélie ^a   Lefranc, Benjamin ^c   Cahard, Dominique ^a   Ségalas Milazzo, Isabelle ^a   Leprince, Jérôme ^b,c   Pannecoucke, Xavier ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b Université de Rouen   (France)

^c UNIVERSITY OF ROUEN   (France)

Author keywords

Biological evaluation; Conformation analysis; Fluoro olefins; Peptides; Pseudopeptides

Indexed keywords

FLUOROOLEFIN; HEPTAPEPTIDE; NEUROPEPTIDE; NEUROPEPTIDE 26RFA; PSEUDOPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CONFORMATION; ENZYMATIC DEGRADATION; FLUORINATION; GENETIC TRANSFECTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SERUM;

BIOLOGICAL EVALUATION; CONFORMATION ANALYSIS; FLUORO-OLEFINS; PEPTIDES; PSEUDOPEPTIDES;

ANIMALS; CALCIUM; CHO CELLS; CRICETULUS; FLUORINE; HALOGENATION; HUMANS; MOLECULAR STRUCTURE; NEUROPEPTIDES; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84883204383     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201300325     Document Type: Article

References (35)

1. N. Chartrel, C. Dujardin, Y. Anouar, J. Leprince, A. Decker, S. Clerens, J. C. Do-Régo, F. Vandesande, C. Llorens-Cortes, J. Costentin, J. C. Beauvillain, H. Vaudry, Proc. Natl. Acad. Sci. USA 2003, 100, 15247-15252.
2. S. Fukusumi, H. Yoshida, R. Fujii, M. Maruyama, H. Komatsu, Y. Habata, Y. Shintani, S. Hinuma, M. Fujino, J. Biol. Chem. 2003, 278, 46387-46395;
3. Y. Jiang, L. Luo, E. L. Gustafson, D. Yadav, M. Laverty, N. Murgolo, G. Vassileva, M. Zeng, T. M. Laz, J. Behan, P. Qiu, L. Wang, S. Wang, M. Bayne, J. Greene, F. Monsma, F. L. Zhang, J. Biol. Chem. 2003, 278, 27652-27657.
4. J. Leprince, C. Neveu, B. Lefranc, L. Guilhaudis, I. Segalas-Milazzo, M. Tena-Sempere, K. Tsutsui, H. Vaudry in Handbook of Biologically Active Peptides, 2nd ed. (Ed.: A. J. Kastin), Academic Press, San Diego, 2013, pp. 917-923.
5. N. Chartrel, J. Alonzeau, D. Alexandre, L. Jeandel, R. Alvear-Perez, J. Leprince, J. Boutin, H. Vaudry, Y. Anouar, C. Llorens-Cortes, Front. Neuroendocrinol. 2011, 32, 387-397.
6. H. Baribault, J. Danao, J. Gupte, L. Yang, B. Sun, W. Richards, H. Tian, Mol. Cell. Biol. 2006, 26, 709-717.
7. J. C. do Régo, J. Leprince, N. Chartrel, H. Vaudry, J. Costentin, Peptides 2006, 27, 2715-2721;
8. V. M. Navarro, R. Fernandez-Fernandez, R. Nogueiras, E. Vigo, S. Tovar, N. Chartrel, O. Le Marec, J. Leprince, E. Aguilar, L. Pinilla, C. Dieguez, H. Vaudry, M. Tena-Sempere, J. Physiol. 2006, 573, 237-249.
9. O. Le Marec, C. Neveu, B. Lefranc, C. Dubessy, J. A. Boutin, J. C. Do Régo, J. Costentin, M. C. Tonon, M. Tena-Sempere, H. Vaudry, J. Leprince, J. Med. Chem. 2011, 54, 4806-4814.
10. C. Neveu, B. Lefranc, O. Tasseau, J. C. Do Régo, A. Bourmaud, P. Chan, P. Bauchat, O. Le Marec, J. Chuquet, L. Guilhaudis, J. A. Boutin, I. Segalas-Milazzo, J. Costentin, H. Vaudry, M. Baudy-Floc'h, D. Vaudry, J. Leprince, J. Med. Chem. 2012, 55, 7516-7524.
11. J.-P. Bégué, D. Bonnet-Delpon in Bioorganic and Medicinal Chemistry of Fluorine, Wiley, Hoboken, NJ, 2008;
12. Fluorine and Health (Eds.: A. Tressaud, G. Haufe), Elsevier, Amsterdam, 2008;
13. Fluorine in Medicinal Chemistry and Chemical Biology (Ed.: I. Ojima), Wiley-Blackwell, Chichester, 2009.
14. R. J. Abraham, S. L. R. Ellison, P. Schonoholzer, W. A. Thomas, Tetrahedron 1986, 42, 2101-2110;
15. P. Cieplack, P. A. Kollman, J. P. Radomski in Biomedical Frontiers of Fluorine Chemistry, Vol. 639 (Eds.: I. Ojima, J. P. McCarthy, J. T. Welch), American Chemical Society, Washington DC, 1996, pp. 143-156;
16. J. J. Urban, B. G. Tillman, W. A. Cronin, J. Phys. Chem. A 2006, 110, 11120-11129;
17. B. E. McKinney, J. J. Urban, J. Phys. Chem. A 2010, 114, 1123-1133.
18. T. Allmendinger, P. Furet, E. Hungerbühler, Tetrahedron Lett. 1990, 31, 7297-7300;
19. T. Allmendinger, E. Felder, E. Hungerbühler, Tetrahedron Lett. 1990, 31, 7301-7304;
20. J. T. Welch, J. Lin, L. G. Boros, B. DeCorte, K. Bergmann, R. Gimi in Biomedical Frontiers of Fluorine Chemistry, Vol. 639 (Eds.: I. Ojima, J. P. McCarthy, J. T. Welch), American Chemical Society, Washington DC, 1996, pp. 129-142;
21. S. Couve-Bonnaire, D. Cahard, X. Pannecoucke, Org. Biomol. Chem. 2007, 5, 1151-1157 and references therein.
22. J. Lin, P. J. Toscano, J. T. Welch, Proc. Natl. Acad. Sci. USA 1998, 95, 14020-14024.
23. G. Dutheuil, S. Couve-Bonnaire, X. Pannecoucke, Angew. Chem. 2007, 119, 1312-1314; Angew. Chem. Int. Ed. 2007, 46, 1290-1292;
24. G. Dutheuil, C. Paturel, X. Lei, S. Couve-Bonnaire, X. Pannecoucke, J. Org. Chem. 2006, 71, 4316-4319;
25. G. Dutheuil, S. Couve-Bonnaire, X. Pannecoucke, Tetrahedron 2009, 65, 6034-6038;
26. C. Pierry, L. Zoute, P. Jubault, E. Pfund, T. Lequeux, D. Cahard, S. Couve-Bonnaire, X. Pannecoucke, Tetrahedron Lett. 2009, 50, 264-266;
27. C. Pierry, D. Cahard, S. Couve-Bonnaire, X. Pannecoucke, Org. Biomol. Chem. 2011, 9, 2378-2386.
28. L. Zoute, G. Dutheuil, J.-C. Quirion, P. Jubault, X. Pannecoucke, Synthesis 2006, 3409-3418;
29. G. Lemonnier, L. Zoute, G. Dupas, J.-C. Quirion, P. Jubault, J. Org. Chem. 2009, 74, 4124-4131.
30. M. K. Edmonds, A. D. Abell, J. Org. Chem. 2001, 66, 3747-3752.
31. Several other dipeptides have been synthesized in the laboratory by the described procedure and were obtained as the desired chiral dipeptides (Ser-Phe, Arg-Phe, etc.). At this point, we do not have any explanation for the racemization process.
32. J. L. Fauchère, C. Thurieau, Adv. Drug Res. 1992, 23, 127-159.
33. K. Wüthrich in NMR of Proteins and Nucleic Acids, Wiley, New York, 1986.
34. D. S. Wishart, C. G. Bigam, A. Holm, R. S. Hodges, B. D. Sykes, J. Biomol. NMR 1995, 5, 67-81.
35. Several attempts to crystallize both analogues LV-2095 and LV-2096 in order to determine the absolute configuration of the stereogenic center in the Phe residue were carried out without success.